Cargando…
When to start: not so fast
It remains controversial whether and, if so, the extent to which antiretroviral therapy (ART) results in net benefit if used by HIV-positive persons with a high CD4 count, particularly those with early HIV infection. This controversy is primarily reflecting lack of solid evidence from randomized con...
Autor principal: | Lundgren, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International AIDS Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512545/ http://dx.doi.org/10.7448/IAS.15.6.18071 |
Ejemplares similares
-
Results of Operative and Nonoperative Treatment of Rockwood Types III and V Acromioclavicular Joint Dislocation: A Prospective, Randomized Trial With an 18- to 20-Year Follow-up
por: Joukainen, Antti, et al.
Publicado: (2014) -
CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression
por: Costagliola, Dominique, et al.
Publicado: (2014) -
When to start: as soon as possible
por: Saag, M
Publicado: (2012) -
Peripartum Outcomes Following COVID-19 Vaccination in Late Pregnancy: Findings from a Population-Based Retrospective Cohort Study in Ontario, Canada
por: El-Chaâr, Darine, et al.
Publicado: (2022) -
Models of care and delivery
por: Lundgren, Jens
Publicado: (2014)